226 results on '"McCusker, Elizabeth"'
Search Results
2. Dusk, blueys beach
3. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
4. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.
5. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
6. A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study
7. Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers
8. Expanding the Allelic Heterogeneity of ANO10-Associated Autosomal Recessive Cerebellar Ataxia
9. End of life: Expert care and support, not physician‐hastened death
10. Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
11. Expanding the Allelic Heterogeneity ofANO10-Associated Autosomal Recessive Cerebellar Ataxia
12. Medical management of motor manifestations of Huntington disease
13. Isolated Craniocervical Dystonia Without Initial Neuropsychiatric Manifestations Associated with NMDA‐Receptor Antibodies
14. Which Basal Ganglia Surgical Targets Ameliorate Parkinsonian Symptoms? : Observations regarding the thalamus and subthalamus
15. Motor onset and diagnosis in Huntington disease using the diagnostic confidence level
16. End of life
17. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
18. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
19. Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses
20. Prevalent Nonmotor Symptoms Associated With Huntington Disease
21. Isolated Craniocervical Dystonia Without Initial Neuropsychiatric Manifestations Associated with NMDA‐Receptor Antibodies.
22. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
23. A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases
24. A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study
25. Design and synthesis of florylpicoxamid, a fungicide derived from renewable raw materials
26. Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology
27. Prevalence of Huntington disease in New South Wales in 1996
28. Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories
29. Late Onset Huntington Disease: Phenotypic and Genotypic Characteristics of 10 Cases in Argentina
30. Age at Onset and Pattern of Neuropsychological Impairment in Mild Early-Stage Alzheimer Disease: A Study of a Community-Based Population
31. Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study
32. Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing
33. Huntington Disease: The ‘typical’ phenotype for the commonest CAG repeat expansion in the ENROLL-HD study across varying functional levels (P4.039)
34. Huntington Disease: The ‘typical’ phenotype for the commonest CAG repeat expansion in the ENROLL-HD study (P4.041)
35. Evaluation of Potential Safety Hazards Associated with the Suzuki–Miyaura Cross-Coupling of Aryl Bromides with Vinylboron Species
36. The specialist neurologist and the 'new genetics'
37. What do we know about Late Onset Huntington’s Disease?
38. Longitudinal Psychiatric Symptoms Progress in Prodromal Huntington Disease: a Decade of Data
39. I14 Predicting individual disease progression in huntington’s disease using mixed models and transition models
40. NMR Chemical Shifts of Trace Impurities: Industrially Preferred Solvents Used in Process and Green Chemistry
41. Evaluation of Potential Safety Hazards Associated with the Suzuki-Miyaura Cross-Coupling of Aryl Bromides with Vinylboron Species.
42. PHARMACOKINETICS OF SODIUM VALPROATE IN SHEEP
43. The Many Facets of Unawareness in Huntington Disease
44. ChemInform Abstract: Asymmetric Homoenolate Additions to Acyl Phosphonates Through Rational Design of a Tailored N-Heterocyclic Carbene Catalyst.
45. ChemInform Abstract: Enantioselective N-Heterocyclic Carbene Catalyzed Annulation Reactions with Imidazolidinones.
46. Asymmetric Homoenolate Additions to Acyl Phosphonates through Rational Design of a Tailored N-Heterocyclic Carbene Catalyst
47. Enantioselective N-Heterocyclic Carbene Catalyzed Annulation Reactions with Imidazolidinones
48. An unusual autopsy case of progressive muscular atrophy with widespread fus positive inclusions
49. Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease?
50. Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.